Doccla, a Swiss startup revolutionizing remote patient monitoring with its innovative “virtual bed” technology, has secured a significant $46 million Series B funding round led by Lakestar. This follows a successful $17 million Series A funding round in September 2022, demonstrating the strong investor confidence in Doccla’s potential to transform healthcare.

Doccla’s unique approach lies in its ability to create a virtual representation of a patient’s hospital bed, capturing vital signs and providing real-time data to healthcare professionals. This data includes physiological indicators like heart rate, oxygen saturation, and respiratory rate, as well as insights into patient movement and activity levels.

The “virtual bed” technology utilizes a combination of sensors, advanced algorithms, and artificial intelligence to monitor patients remotely, offering a comprehensive and continuous picture of their health. This allows doctors to detect potential complications early on and intervene proactively, ensuring optimal patient care.

Doccla’s technology holds immense promise for improving healthcare outcomes in various settings, including:

Home Care: Patients can recover in the comfort of their own homes while receiving professional monitoring and support. This not only reduces hospital readmissions but also improves patient satisfaction and quality of life.

Assisted Living: The system can empower caregivers in assisted living facilities to better understand resident needs, allowing for timely interventions and personalized care plans.

Hospitals: By providing real-time data on patient status, Doccla can help healthcare professionals optimize staffing, allocate resources efficiently, and ensure timely response to changes in patient condition.

The new funding will enable Doccla to accelerate its expansion plans, further develop its technology, and increase its global reach. The company aims to collaborate with healthcare providers and insurance companies to integrate its “virtual bed” solution into their existing workflows, making remote patient monitoring accessible to a wider range of patients.

Doccla’s vision is to empower individuals to take control of their health and well-being. The company believes that by leveraging technology and innovative solutions, they can contribute to a future where healthcare is more personalized, proactive, and accessible for everyone.

The Series B funding is a significant milestone for Doccla and a testament to the growing recognition of the importance of remote patient monitoring in modern healthcare. With its innovative technology and commitment to improving patient outcomes, Doccla is poised to revolutionize the way healthcare is delivered, ushering in a new era of personalized and connected care.